Global Retinal Drugs and Biologics Market Research Report 2019

Published On: Sep 2019

Format: PDF

Publisher: QY Research

Pages: 110

Report ID: 61435

A biologic is manufactured in a living system such as a microorganism, or plant or animal cells. Most biologics are very large, complex molecules or mixtures of molecules. Many biologics are produced using recombinant DNA technology.
Global Retinal Drugs and Biologics market is highly fragmented with the presence of multiple players.


This report studies the global Retinal Drugs and Biologics market status and forecast, categorizes the global Retinal Drugs and Biologics market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech 
OCULAR THERAPEUTIX
Bausch & Lomb
UCBCares

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospitals
Clinics
Others

The study objectives of this report are:
To analyze and study the global Retinal Drugs and Biologics capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Retinal Drugs and Biologics manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Retinal Drugs and Biologics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Retinal Drugs and Biologics Manufacturers
Retinal Drugs and Biologics Distributors/Traders/Wholesalers
Retinal Drugs and Biologics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Retinal Drugs and Biologics market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Retinal Drugs and Biologics Market Research Report 2018
1 Retinal Drugs and Biologics Market Overview
1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Retinal Drugs and Biologics Segment by Type (Product Category)
1.2.1 Global Retinal Drugs and Biologics Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Retinal Drugs and Biologics Production Market Share by Type (Product Category) in 2017
1.2.3 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.5 Ocular Inflammatory Disease (Uveitis)
Macular Hole
1.3 Global Retinal Drugs and Biologics Segment by Application
1.3.1 Retinal Drugs and Biologics Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Retinal Drugs and Biologics Market by Region (2013-2025)
1.4.1 Global Retinal Drugs and Biologics Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Retinal Drugs and Biologics (2013-2025)
1.5.1 Global Retinal Drugs and Biologics Revenue Status and Outlook (2013-2025)
1.5.2 Global Retinal Drugs and Biologics Capacity, Production Status and Outlook (2013-2025)

2 Global Retinal Drugs and Biologics Market Competition by Manufacturers
2.1 Global Retinal Drugs and Biologics Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Retinal Drugs and Biologics Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Retinal Drugs and Biologics Production and Share by Manufacturers (2013-2018)
2.2 Global Retinal Drugs and Biologics Revenue and Share by Manufacturers (2013-2018)
2.3 Global Retinal Drugs and Biologics Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Retinal Drugs and Biologics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Retinal Drugs and Biologics Market Competitive Situation and Trends
2.5.1 Retinal Drugs and Biologics Market Concentration Rate
2.5.2 Retinal Drugs and Biologics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Retinal Drugs and Biologics Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Retinal Drugs and Biologics Capacity and Market Share by Region (2013-2018)
3.2 Global Retinal Drugs and Biologics Production and Market Share by Region (2013-2018)
3.3 Global Retinal Drugs and Biologics Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global Retinal Drugs and Biologics Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Retinal Drugs and Biologics Consumption by Region (2013-2018)
4.2 North America Retinal Drugs and Biologics Production, Consumption, Export, Import (2013-2018)
4.3 Europe Retinal Drugs and Biologics Production, Consumption, Export, Import (2013-2018)
4.4 China Retinal Drugs and Biologics Production, Consumption, Export, Import (2013-2018)
4.5 Japan Retinal Drugs and Biologics Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Retinal Drugs and Biologics Production, Consumption, Export, Import (2013-2018)
4.7 India Retinal Drugs and Biologics Production, Consumption, Export, Import (2013-2018)

5 Global Retinal Drugs and Biologics Production, Revenue (Value), Price Trend by Type
5.1 Global Retinal Drugs and Biologics Production and Market Share by Type (2013-2018)
5.2 Global Retinal Drugs and Biologics Revenue and Market Share by Type (2013-2018)
5.3 Global Retinal Drugs and Biologics Price by Type (2013-2018)
5.4 Global Retinal Drugs and Biologics Production Growth by Type (2013-2018)

6 Global Retinal Drugs and Biologics Market Analysis by Application
6.1 Global Retinal Drugs and Biologics Consumption and Market Share by Application (2013-2018)
6.2 Global Retinal Drugs and Biologics Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Retinal Drugs and Biologics Manufacturers Profiles/Analysis
7.1 ALLERGAN
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 ALLERGAN Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 AbbVie
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 AbbVie Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Alimera Sciences
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Alimera Sciences Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Janssen Biotech
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Janssen Biotech Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Swedish Orphan Biovitrum
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Roche
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Roche Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Bristol-Myers Squibb
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Genzyme
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Genzyme Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Genentech 
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Genentech  Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 OCULAR THERAPEUTIX
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Retinal Drugs and Biologics Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Bausch & Lomb
7.12 UCBCares

8 Retinal Drugs and Biologics Manufacturing Cost Analysis
8.1 Retinal Drugs and Biologics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Retinal Drugs and Biologics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Retinal Drugs and Biologics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Retinal Drugs and Biologics Major Manufacturers in 2017
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Retinal Drugs and Biologics Market Forecast (2018-2025)
12.1 Global Retinal Drugs and Biologics Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Retinal Drugs and Biologics Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Retinal Drugs and Biologics Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Retinal Drugs and Biologics Price and Trend Forecast (2018-2025)
12.2 Global Retinal Drugs and Biologics Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Retinal Drugs and Biologics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Retinal Drugs and Biologics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Retinal Drugs and Biologics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Retinal Drugs and Biologics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Retinal Drugs and Biologics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Retinal Drugs and Biologics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Retinal Drugs and Biologics Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Retinal Drugs and Biologics Consumption Forecast by Application (2018-2025)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer